LIDDS publishes agenda for the company’s Capital Markets Day 2022
UPPSALA, SWEDEN – LIDDS AB (publ) announced today the agenda for the Capital Markets Day…
UPPSALA, SWEDEN – LIDDS AB (publ) announced today the agenda for the Capital Markets Day…
San Jose, California, United States, March 04, 2022 (GLOBE NEWSWIRE) — Fastmetrics, the Official Business…
Faster and safer cloud migrations enabled through close technical integration PARIS and BONN, Germany, March…
New Delhi, India–(Newsfile Corp. – March 4, 2022) – The Metaverse Industry has taken the…
Honor marks company’s third KI Award CLEVELAND–(BUSINESS WIRE)–Frontline International is proud to be honored as…
Registration now open for March 17 and April 21 events MINNEAPOLIS–(BUSINESS WIRE)–As part of its…
Shareholders approve 25th consecutive dividend increase to CHF 3.10 (+3.3%) per share for 2021; representing…
WALTHAM, Mass., March 04, 2022 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company…
EMERYVILLE, Calif., March 04, 2022 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader…
SAN CARLOS, Calif., March 04, 2022 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
MIAMI, March 04, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company…
SAN DIEGO, March 04, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage…
NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…
Two podium and one poster presentation share important new findings on FINTEPLA’s safety profile and…
BOSTON and LAUSANNE, Switzerland, March 04, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH),…
– Toripalimab plus chemotherapy demonstrates improvement in co-primary endpoints of PFS and OS in patients…
TORONTO, March 04, 2022 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
– Toripalimab plus chemotherapy demonstrates improvement in co-primary endpoints of PFS and OS in patients…
SAN DIEGO, March 04, 2022 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), today announced…